Advertisement

Effect of NFκB Inhibition by CAPE on Skeletal Muscle Ischemia-Reperfusion Injury

      Background/Aims

      Nuclear factor kappa B (NFκB) plays important role in the pathogenesis of skeletal muscle ischemia/reperfusion (I/R) injury. Caffeic acid phenyl ester (CAPE), a potent NFκB inhibitor, exhibits protective effects on I/R injury in some tissues. In this report, the effect of CAPE on skeletal muscle I/R injury in rats was studied.

      Methods

      Wistar rats were submitted to sham operation, 120-min hindlimb ischemia, or 120-min hindlimb ischemia plus saline or CAPE treatment followed by 4-h reperfusion. Gastrocnemius muscle injury was evaluated by serum aminotransferase levels, muscle edema, tissue glutathione and malondialdehyde measurement, and scoring of histological damage. Apoptotic nuclei were determined by a terminal uridine deoxynucleotidyl transferase dUTP nick end labeling assay. Muscle neutrophil and mast cell accumulation were also assessed. Lipoperoxidation products and NFκB were evaluated by 4-hydroxynonenal and NFκB p65 immunohistochemistry, respectively.

      Results

      Animals submitted to ischemia showed a marked increase in aminotransferases after reperfusion, but with lower levels in the CAPE group. Tissue glutathione levels declined gradually during ischemia to reperfusion, and were partially recovered with CAPE treatment. The histological damage score, muscle edema percentage, tissue malondialdehyde content, apoptosis index, and neutrophil and mast cell infiltration, as well as 4-hydroxynonenal and NFκB p65 labeling, were higher in animals submitted to I/R compared with the ischemia group. However, the CAPE treatment significantly reduced all of these alterations.

      Conclusions

      CAPE was able to protect skeletal muscle against I/R injury in rats. This effect may be associated with the inhibition of the NFκB signaling pathway and decrease of the tissue inflammatory response following skeletal muscle I/R.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Surgical Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kerrigan C.L.
        • Stotland M.A.
        Ischemia reperfusion injury: A review.
        Microsurgery. 1993; 14: 165
        • Schlag M.G.
        • Harris K.A.
        • Potter R.F.
        Role of leukocyte accumulation and oxygen radicals in ischemia-reperfusion-induced injury in skeletal muscle.
        Am J Physiol Heart Circ Physiol. 2001; 280: H1716
        • Blaisdell F.W.
        The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: A review.
        Cardiovasc Surg. 2002; 10: 620
        • Woodruff T.M.
        • Arumugam T.V.
        • Shiels I.A.
        Protective effects of a potent C5a receptor antagonist on experimental acute limb ischemia-reperfusion in rats.
        J Surg Res. 2004; 116: 81
        • Gute D.C.
        • Ishida T.
        • Yarimizu K.
        • et al.
        Inflammatory responses to ischemia and reperfusion in skeletal muscle.
        Mol Cell Biochem. 1998; 179: 169
        • Grisotto P.C.
        • Santos A.C.
        • Coutinho-Neto J.
        • et al.
        Indicators of oxidative injury and alterations of the cell membrane in the skeletal muscle of rats submitted to ischemia and reperfusion.
        J Surg Res. 2000; 92: 1
        • Gilmore T.D.
        Introduction to NF-κB: Players, pathways, perspectives.
        Oncogene. 2006; 25: 6680
        • Lille S.T.
        • Lefler S.R.
        • Mowlavi A.
        • et al.
        Inhibition of the initial wave of NF-κB activity in rat muscle reduces ischemia/reperfusion injury.
        Muscle Nerve. 2001; 24: 534
        • Sasaki H.
        • Zhu L.
        • Fukuda S.
        • et al.
        Inhibition of NF-κB activation by pyrrolidine dithiocarbamate prevents in vivo hypoxia/reoxygenation-mediated myocardial angiogenesis.
        Int J Tissue React. 2000; 22: 93
        • Zou L.
        • Attuwaybi B.
        • Kone B.C.
        Effects of NF-κB inhibition on mesenteric ischemia-reperfusion injury.
        Am J Physiol Gastrointest Liver Physiol. 2003; 284: G713
        • Howard E.F.
        • Chen Q.
        • Cheng C.
        • et al.
        NF-κB is activated and ICAM-1 gene expression is up-regulated during reoxygenation of human brain endothelial cells.
        Neurosci Lett. 1998; 248: 199
        • Yoshidome H.
        • Kato A.
        • Edwards M.J.
        • et al.
        Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: Implications of a central role for nuclear factor κB.
        Hepatology. 1999; 30: 203
        • Donnahoo K.K.
        • Meldrum D.R.
        • Shenkar R.
        • et al.
        Early renal ischemia, with or without reperfusion, activates NFκB and increases TNF-α bioactivity in the kidney.
        J Urol. 2000; 163: 1328
        • Ross S.D.
        • Kron I.L.
        • Gangemi J.J.
        • et al.
        Attenuation of lung reperfusion injury after transplantation using an inhibitor of nuclear factor-κB.
        Am J Physiol Lung Cell Mol Physiol. 2000; 279: L528
        • Qi W.-N.
        • Chaiyakit P.
        • Cai Y.
        • et al.
        NF-κB p65 involves in reperfusion injury and iNOS gene regulation in skeletal muscle.
        Microsurgery. 2004; 24: 316
        • Park J.W.
        • Qi W.N.
        • Cai Y.
        • et al.
        Proteasome inhibitor attenuates skeletal muscle reperfusion injury by blocking the pathway of nuclear factor-κB activation.
        Plast Reconstr Surg. 2007; 120: 1808
        • Fidan H.
        • Sahin O.
        • Yavuz Y.
        • et al.
        Caffeic acid phenethyl ester reduces mortality and sepsis-induced lung injury in rats.
        Crit Care Med. 2007; 35: 2822
        • Fesen M.R.
        • Pommier Y.
        • Leteurtre F.
        • et al.
        Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds.
        Biochem Pharmacol. 1994; 48: 595
        • Chung T.W.
        • Moon S.K.
        • Chang Y.C.
        • et al.
        Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: Complete regression of hepatoma growth and metastasis by dual mechanism.
        FASEB J. 2004; 18: 1670
        • Ozyurt B.
        • Iraz M.
        • Koca K.
        • et al.
        Protective effects of caffeic acid phenethyl ester on skeletal muscle ischemia-reperfusion injury in rats.
        Mol Cell Biochem. 2006; 292: 197
        • Ozyurt H.
        • Ozyurt B.
        • Koca K.
        • et al.
        Caffeic acid phenethyl ester (CAPE) protects rat skeletal muscle against ischemia-reperfusion-induced oxidative stress.
        Vascul Pharmacol. 2007; 47: 108
        • Koltuksuz B.U.
        • Özen S.
        • Uz E.
        • et al.
        Caffeic acid phenethyl ester prevents intestinal reperfusion injury in rats.
        J Pediatr Surg. 1999; 34: 1458
        • Irmak M.K.
        • Koltuksuz U.
        • Kutlu N.O.
        • et al.
        The effect of caffeic acid phenethyl ester on ischemia-reperfusion injury in comparison with α-tocopherol in rat kidneys.
        Urol Res. 2001; 29: 190
        • Uz E.
        • Sogut S.
        • Sahin S.
        • et al.
        The protective role of caffeic acid phenethyl ester (CAPE) on testicular tissue after testicular torsion and detorsion.
        World J Urol. 2002; 20: 264
        • Khan M.
        • Elango C.
        • Ansari M.A.
        • et al.
        Caffeic acid phenethyl ester reduces neurovascular inflammation and protects rat brain following transient focal cerebral ischemia.
        J Neurochem. 2007; 102: 365
        • Natarajan K.
        • Singh S.
        • Burke T.R.
        • et al.
        Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-κB.
        Proc Natl Acad Sci USA. 1996; 93: 9090
        • Strock P.E.
        • Majno G.
        Vascular responses to experimental tourniquet ischemia.
        Surg Gynecol Obstet. 1969; 129: 309
        • Herbert K.J.
        • Hickey M.J.
        • Lepore D.A.
        • et al.
        Effects of the endothelin receptor antagonist Bosentan on ischemia/reperfusion injury in rat skeletal muscle.
        Eur J Pharmacol. 2001; 424: 59
        • Erkanli K.
        • Kayalar N.
        • Erkanli G.
        • et al.
        Melatonin protects against ischemia/reperfusion injury in skeletal muscle.
        J Pineal Res. 2005; 39: 238
        • Suetsugu H.
        • Iimuro Y.
        • Uehara T.
        • et al.
        Nuclear factor κB inactivation in the rat liver ameliorates short term total warm ischemia/reperfusion injury.
        Gut. 2005; 54: 835
        • Kohli R.
        • Harris D.C.
        • Whitington P.F.
        Relative elevations of serum alanine and aspartate aminotransferase in muscular dystrophy.
        J Pediatr Gastroenterol Nutr. 2005; 41: 121
        • Seal J.B.
        • Gewertz B.L.
        Vascular dysfunction in ischemia-reperfusion injury.
        Ann Vasc Surg. 2005; 19: 1
        • Sud'ina G.F.
        • Mirzoeva O.K.
        • Pushkareva M.A.
        • et al.
        Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties.
        FEBS. 1993; 329: 21
        • Su M.
        • Chi E.Y.
        • Bishop M.J.
        • et al.
        Lung mast cells increase in number and degranulate during pulmonary artery occlusion/reperfusion injury in dogs.
        Am Rev Respir Dis. 1993; 147: 448
        • Kanwar S.
        • Kubes P.
        Mast cells contribute to ischemia-reperfusion-induced granulocyte infiltration and intestinal dysfunction.
        Am J Physiol. 1994; 267: G316
        • Patella V.
        • Marino I.
        • Arbustini E.
        • et al.
        Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy.
        Circulation. 1998; 97: 971
        • Lazarus B.
        • Messina A.
        • Barker J.E.
        • et al.
        The role of mast cells in ischemia-reperfusion injury in murine skeletal muscle.
        J Pathol. 2000; 191: 443
        • Bortolotto S.K.
        • Morrison W.A.
        • Han X.
        • et al.
        Mast cells play a pivotal role in ischemia reperfusion injury to skeletal muscles.
        Lab Invest. 2004; 84: 1103
        • Zhang F.
        • Hu E.C.
        • Gerzenshtein J.
        • et al.
        The expression of proinflammatory cytokines in the rat muscle flap with ischemia-reperfusion injury.
        Ann Plast Surg. 2005; 54: 313
        • Tsoulfas G.
        • Geller D.A.
        NF-κB in transplantation: Friend or foe?.
        Transpl Infect Dis. 2001; 3: 212
        • Monici M.C.
        • Aguennouz M.
        • Mazzeo A.
        • et al.
        Activation of nuclear factor-κB in inflammatory myopathies and Duchenne muscular dystrophy.
        Neurology. 2003; 25: 993
        • Fan H.
        • Sun B.
        • Gu Q.
        • et al.
        Oxygen radicals trigger activation of NF-κB and AP-1 and up-regulation of ICAM-1 in reperfused canine heart.
        Am J Physiol Heart Circ Physiol. 2002; 282: H1778
        • Maekawa N.
        • Wada H.
        • Kanda T.
        • et al.
        Improved myocardial ischemia/reperfusion injury in mice lacking tumor necrosis factor-α.
        J Am Coll Cardiol. 2002; 39: 1229
        • Marquardt D.L.
        • Walker L.L.
        Dependence of mast cell IgE-mediated cytokine production on nuclear factor-κB activity.
        J Allergy Clin Immunol. 2000; 105: 500
        • Peng Y.
        • Power M.R.
        • Li B.
        • et al.
        Inhibition of IKK down-regulates antigen + IgE-induced TNF production by mast cells: A role for the IKK-IκB-NF-κB pathway in IgE-dependent mast cell activation.
        J Leukoc Biol. 2005; 77: 975
        • Rushing G.D.
        • Britt L.D.
        Inhibition of NF-κB does not induce C-Jun N-terminal Kinase-mediated apoptosis in reperfusion injury.
        J Am Coll Surg. 2007; 204: 964